approved EB-2 (NIW)

Associate Research Scientist

Organic Chemistry · Vietnam · 2022-04-13

Processing Time
820 days
Decision Date
2022-04-13
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research on designing, synthesizing, and analyzing the structures of organic compounds, including natural products and synthetic organic compounds. This work aims to discover new therapeutic drugs and improve the processes used to design and produce pharmaceuticals.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research is of great importance as it improves drug design and production processes for the pharmaceutical industry.

2 Well-positioned to Advance the Endeavor Met

The petitioner's education, experience, and documented record of success, including federal grant support, well-position him to advance his work.

3 Waiver Benefit Met

On balance, the petitioner's contributions and the national interest served by his research justify a waiver of the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in organic chemistry and a record of 5 peer-reviewed journal articles and one book chapter with 36 citations. Evidence included 3 peer reviews for international journals, 5 expert recommendation letters, and proof of research support from the NIH, NSF, and National Institute of Drug Abuse.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Others

Pharmaceuticals · Taiwan

WeGreened EB-2 (NIW) approved
Georgia 303 days 2025-03-25
The petitioner proposes to utilize organic synthesis and structure-activity relationship (SAR) studies to develop new pharmaceutical compounds. The work focuses on creating novel chemical motifs and predictive modeling to improve therapies for antimicrobial-resistant infections and mitigate critical drug shortages.

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
Wisconsin 94 days 2025-01-29
The petitioner proposes to investigate the design, synthesis, optimization, and characterization of small molecule compounds. This work focuses on developing therapeutic agents to address drug-resistant infections and improve medication safety and efficacy.

Postdoctoral Researcher

Pharmaceuticals · Vietnam

WeGreened EB-2 (NIW) approved
278 days 2025-01-11
The petitioner proposes to identify and analyze novel bioactive compounds isolated from natural sources with distinct chemical diversity. This work aims to accelerate the development of new pharmaceuticals for chronic diseases that currently lack adequate treatments, such as diabetes, cardiovascular disease, and osteoporosis.

Chemist

Pharmaceuticals · China

WeGreened EB-2 (NIW) rfe approved
Pennsylvania 364 days 2025-11-26
The petitioner proposes to develop practical and efficient synthetic routes to produce active pharmaceutical ingredients (APIs) for drugs currently in clinical trials. This work focuses on improving scalable production methods to reduce costs and shorten development timelines for new therapies targeting cancer and neurodegenerative disorders.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-04-13.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 820 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist